Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Sep 1, 2006

Preliminary injunction ordered in PLAVIX® patent infringement case - Apotex to halt sales of unauthorized generic
Aug 17, 2006

FDA approves new indication for PLAVIX® (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack

Expands PLAVIX Indication to include patients with any acute coronary syndromes (ACS)
Aug 14, 2006

The U.S. Food and Drug Administration approves ACTONEL® for broader use in men with osteoporosis

12 Million Men in U.S. at Risk for this Fragile Bone Disease
Aug 2, 2006

Sanofi-aventis Announces First half of 2006: Sales growth of 7.7% on a reported basis and 4.5% on a comparable basis - Adjusted EPS growth of 32.9%,or 16.1% excluding selected items
Jul 12, 2006

New data support long-term use of AMBIEN CR™ (zolpidem tartrate extended-release) Tablets CIV for up to 24 weeks

Results extending the role of AMBIEN CR in the treatment of insomnia presented at the 2006 CINP (Collegium Internationale Neuro-Psychopharmacologicum) 25th Biennial Congress

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.